Laurimic

Fenticonazole nitrate, the active ingredient in Laurimic, is an imidazole antifungal presented as a vaginal formulation for local use. It treats vaginal candidiasis and vulvovaginal yeast infections in adult women. Laurimic is supplied as a prescription‑only product for targeted antifungal therapy.

GNH USA supplies Laurimic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laurimic is an imidazole antifungal that acts on Candida species causing vaginal infections.

- Vaginal candidiasis: eliminates the fungal infection and relieves associated symptoms such as itching and discharge. - Vulvovaginal yeast infection: clears yeast overgrowth and reduces irritation and discomfort. - Candidal vaginitis: restores normal vaginal flora and prevents recurrence of infection.

Common Side Effects: - Vaginal irritation: mild burning or stinging at the application site. - Itching: localized pruritus within the vagina. - Abnormal discharge: temporary changes in vaginal fluid. - Unpleasant odor: transient odor alteration after use.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives indicating hypersensitivity. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: signs of liver injury such as jaundice. - Severe vaginal ulceration: painful ulcer formation requiring medical attention.

Before using Laurimic, consider the following precautions. - Pregnancy: safety not established; use only if clearly needed after risk‑benefit assessment. - Breastfeeding: unknown safety; consult a healthcare professional. - Allergic history: avoid if known hypersensitivity to imidazole antifungals. - Concomitant vaginal products: do not use other medicated vaginal preparations simultaneously. - Application technique: follow product instructions to ensure proper insertion and dosage. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Laurimic may interact with other medications as described below.

Major Interactions (Avoid): - Systemic azoles: concurrent use may increase systemic exposure and toxicity. - Estrogen‑containing vaginal creams: may reduce antifungal efficacy.

Moderate Interactions (Monitor Closely): - Other topical antifungals: overlapping use can increase local irritation. - Spermicidal products: may alter drug absorption and effectiveness. - Oral contraceptives: monitor for any changes in menstrual patterns, though clinical significance is low.